Markets are beginning the week on a positive note amid very light volume ahead of the long holiday weekend.   Read More

An interview with Liberty Media CEO Greg Maffei on Squawk Box had some interesting moments this morning. I asked Maffei whether he would be interested in taking the top job at Direct TV, which long time CEO Chase Carey recently departed to take the number two job at Newscorp.   Read More

The Mad Money host defends the Federal Reserve chairman against claims of impropriety. Plus, a reaction to the central bank leaving interest rates unchanged.   Read More

It's sounds almost simplistic to say that Oracle's spacer shares will only move tonight after the company reports its fourth quarter earnings with a sizeable surprise, either to the up or downside. And some analysts I'm talking to say that surprise, to the upside, is indeed a real possibility.    Read More

The firestorm caused by Rio Tinto pulling out of its deal with Chinalco, resulting from the partnership with once bitter rival, BHP Billiton, has the makings of a soap drama. It's enthralling viewing, but many observers are missing the vital sub-plot which leads to the surprise ending.    Read More

All week we were waiting for the official word that BlackRock would buy Barclay’s, BGI (Barclays Global Investors). They finally sealed the deal on Thursday evening.    Read More

Based on an e-mail alert The Globe just sent out, it appears the paper is business as usual, announcing a new editor of the editorial page, while the current editor becomes head of the Globe's editorial board. But will the Globe be around to have an editorial page?    Read More

To almost no one's surprise, for the first time in 41 years, the World Health Organization has declared a full-blown swine flu pandemic. But the declaration is tied more to the geographic spread of the virus than it is to its virulence.    Read More

"It's a risky business." I don't think I'll ever forget when a Chief Financial Officer said that at an investor conference last year in lieu of reading the whole boring boilerplate "Safe Harbor Statement."    Read More

In less than two weeks, there've been four pretty significant events in biopharma. And, hopefully, after ADA things will begin to settle down a bit for the summer.    Read More